| 000 | 01359 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513141955.0 | ||
| 264 | 0 | _c19980521 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBernhard, E J | |
| 245 | 0 | 0 |
_aInhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. _h[electronic resource] |
| 260 |
_bCancer research _cApr 1998 |
||
| 300 |
_a1754-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGenes, ras _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethionine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aProtein Prenylation _xphysiology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xmetabolism |
| 650 | 0 | 4 |
_aRadiation Tolerance _xdrug effects |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aMcKenna, W G | |
| 700 | 1 | _aHamilton, A D | |
| 700 | 1 | _aSebti, S M | |
| 700 | 1 | _aQian, Y | |
| 700 | 1 | _aWu, J M | |
| 700 | 1 | _aMuschel, R J | |
| 773 | 0 |
_tCancer research _gvol. 58 _gno. 8 _gp. 1754-61 |
|
| 999 |
_c9530571 _d9530571 |
||